WEIGHT LOSS DRUG QSYMIA APPROVED FOR USE IN US

The US Food and Drug Administration (FDA) has approved a new weight-loss drug from the pharmaceutical company Vivus. The FDA approved Qsymia for patients who are overweight or obese and have at least one other weight-related condition.

The FDA said that two studies conducted on patients who took Qsymia, along with changing their diet and increasing exercise, showed an average weight loss of 6.7% and 8.9%.

However, the drug can increase heart rate and will therefore not be recommended for patients with heart disease or who have recently suffered a stroke.

Vivus will also have to carry our further trials to assess the impact of the drug on cardiac health.

Pregnant women are another group who must not use the drug, as it can cause harm to foetuses, the FDA said.

Qsymia is a combination of two drugs already approved by the FDA, phentermine and topiramate. Those drugs are marketed for aiding weight loss and preventing seizures respectively.

For the full article: BBC News

 

About these ads

One response to “WEIGHT LOSS DRUG QSYMIA APPROVED FOR USE IN US

  1. No one is talking about how serious some of these side effects are. This new diet drug is only for people suffering serious weight problems and not the average dieter. The known side effects of Qsymia are serious and people need to see a doctor about this drug.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s